Kollins John A - Insider Non-Derivative Transactions at Satsuma Pharmaceuticals, Inc. (STSA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 6, 2023, Kollins John A's relationship to Satsuma Pharmaceuticals, Inc. (STSA) is Director,Officer (President and CEO), and currently has 0 shares of Common Stock, $0.0001 par value.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other STSA insiders.
Data Source: SEC.
Kollins John A - Insider Non-Derivative Transactions at STSA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 7, 2023 | U -- (Common Stock, $0.0001 par value) | 305911 | 0.91 | 0 |